{
  "id": "bb4a962ea604995e",
  "title": "Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys\u00ae for the Treatment of ADHD",
  "description": "20260106T073000Z",
  "content": "",
  "source": "portal.sina.com.hk",
  "source_url": "https://portal.sina.com.hk/finance/finance-prnewswire/prnasia/2026/01/06/1429450/ark-biopharmaceutical-receives-china-marketing-authorization-for-azstarys-for-the-treatment-of-adhd/",
  "published_at": "20260106T073000Z",
  "fetched_at": "2026-01-07T00:22:40.638561+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "china"
  ],
  "location": "Hong Kong",
  "raw_data": {
    "url": "https://portal.sina.com.hk/finance/finance-prnewswire/prnasia/2026/01/06/1429450/ark-biopharmaceutical-receives-china-marketing-authorization-for-azstarys-for-the-treatment-of-adhd/",
    "url_mobile": "",
    "title": "Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys\u00ae for the Treatment of ADHD",
    "seendate": "20260106T073000Z",
    "socialimage": "",
    "domain": "portal.sina.com.hk",
    "language": "English",
    "sourcecountry": "Hong Kong"
  }
}